Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing
Technology and Health Care · 2023
DOI: 10.3233/thc-220102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology and Health Care, 2023. Verfasst von Wenxin Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of In Vitro Diagnostic Reagent, National Institutes for Food and Drug Control (NIFDC), Beijing, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins p21(ras). Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Along with the dramatic development of molecular diagnostic testing for the detection of oncogene variations, reference materials (RMs) have become increasingly important in performance evaluation of genetic testing. OBJECTIVE: In this study, we built a set of RMs for genetic testing based on next-generation sequencing (NGS). METHOD: Solid tumor tissues were selected as the samples of RMs for preparation. NGS was used to determine and validate the variants and the mutation frequency in DNA samples. Digital PCR was used to determine the copy numbers of RNA samples. The performance of the RMs was validated by six laboratories. RESULTS: Thirty common genetic alterations were designed based on these RMs. RMs consisted of a positive reference, a limit of detection reference, and a negative reference. The validation results confirmed the performance of the RMs. CONCLUSION: These RMs may be an attractive tool for the development, validation, and quality monitoring of molecular genetic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of In Vitro Diagnostic Reagent, National Institutes for Food and Drug Control (NIFDC), Beijing, China.
- Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China.
- Medical Research Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- BGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong, China.
- Geneplus-Beijing Clinical Laboratory Co., Ltd., Beijing, China.
- Novogene (Tianjin) Bioinformatics Technology Co., Ltd., Tianjin, China.
Zitieren
APA
Zhang, W., Qu, S., Chen, Q., Yang, X., Yu, J., Zeng, S., Chu, Y., Zou, H., Zhang, Z., Wang, X., Jing, R., Wu, Y., Liu, Z., Xu, R., Wu, C., Huang, C., & Huang, J. (2023). Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing. Technology and Health Care. https://doi.org/10.3233/thc-220102
Vancouver
Zhang W, Qu S, Chen Q, Yang X, Yu J, Zeng S, et al. Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing. Technology and Health Care. 2023. doi:10.3233/thc-220102
BibTeX
@article{Zhang2023,
author = {Zhang, Wenxin and Qu, Shoufang and Chen, Qiong and Yang, Xuexi and Yu, Jing and Zeng, Shuang and Chu, Yuxing and Zou, Hao and Zhang, Zhihong and Wang, Xiaowen and Jing, Ruilin and Wu, Yingsong and Liu, Zhipeng and Xu, Ren and Wu, Chunyan and Huang, Chuanfeng and Huang, Jie},
title = {Development and characterization of reference materials for EGFR, KRAS, NRAS, BRAF, PIK3CA, ALK, and MET genetic testing},
journal = {Technology and Health Care},
year = {2023},
doi = {10.3233/thc-220102}
}
EUVIMED